Charles Schwab Investment Management Inc Imara Inc. Transaction History

Charles Schwab Investment Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$3.73 - $5.2 $42,965 - $59,898	11,519 New	11,519 $47,000
Q3 2021 Nov 16, 2021	SELL	$4.08 - $7.83 $74,598 - $143,163	-18,284 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$6.78 - $9.04 $104,859 - $139,812	-15,466 Reduced 45.83%	18,284 $145,000
Q1 2021 May 17, 2021	SELL	$8.18 - $23.98 $11,419 - $33,476	-1,396 Reduced 3.97%	33,750 $285,000
Q4 2020 Feb 16, 2021	BUY	$15.81 - $29.0 $51,192 - $93,902	3,238 Added 10.15%	35,146 $775,000
Q3 2020 Nov 13, 2020	SELL	$18.75 - $28.58 $14,887 - $22,692	-794 Reduced 2.43%	31,908 $650,000
Q2 2020 Aug 14, 2020	BUY	$15.6 - $54.87 $510,151 - $1.79 Million	32,702 New	32,702 $904,000

104K

170K

Ticker IMRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,287,300
Market Cap $552M
Description
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.